Are traditional on-site clinical trials a thing of the past? Our latest blog explores how decentralised clinical trials (DCTs) offer a new approach to conducting clinical research. https://t.co/kSRudosfVv #clinicaltrials #rct #dct #decentralizedtrials #nof1trials

The new FDA Rare Disease Innovation Hub will revolutionise rare disease treatment, by focusing on innovative trial designs, real-world evidence, and more - 🔗 https://t.co/ItBQ8afLTL #clinicaltrials #personalisedmedicine #FDA #Nof1 #Nof1Trials #medicalresearch #raredisease

We went through the 2024 MTPConnect Australia’s Clinical Trials Sector Report so you didn’t have to! Discover 3 Key Insights that will shape the future of clinical trials👉 Read the full blog post here: https://t.co/PbiwIvbcpa #Nof1 #Clinicaltrials #mtpconnect #clinicalresearch

🔊 An update from Bob Brown outside the courthouse today after he was found guilty for peacefully defending Swift Parrot habitat. #EndNativeForestLogging #politas

N-of-1 Hub is a National Finalist in the 2024 Australian Women’s Small Business Champion Awards for Professional Medical Services! 🌟 Selected from 3,000+ entries, this honour reflects our team's dedication. Thanks to our amazing clients! Winners announced August 24th!

N-of-1 Hub is a National Finalist in the 2024 Australian Women’s Small Business Champion Awards for Professional Medical Services! 🌟 Selected from 3,000+ entries, this honour reflects our team's dedication. Thanks to our amazing clients! Winners announced August 24th!

We are looking for AUS Physiotherapists to participate in research about N-of-1 trials and single-case studies in clinical practice. Interviews avail in person or by phone or Zoom https://t.co/u89TCSHq7A @JaneNikles @suzannem5 @MicheleSterlin7 @meganhross @vianavuvan

Congrats to #UQ’s Queensland Aphasia Research Centre (QARC) for receiving the #NHMRC Consumer Engagement Award! The Centre was recognised for its exceptional contribution to community health and medical research for people with #aphasia. Read more https://t.co/7dqou9yoSR

@Nof1symposium @MariolaMoeyaert @jonathanjevans @suzannem5 @JaneNikles @PatrickOnghena @wicksell_rikard @JohannesVlaeyen

Please RT ⬆️ : @suzannem5 @JaneNikles @PatrickOnghena @wicksell_rikard @JohannesVlaeyen @SamuelDCalder @SRHarvey_ @crichton_ali @Nof1symposium

@Nof1symposium @suzannem5 @JaneNikles @PatrickOnghena @wicksell_rikard @JohannesVlaeyen

#FollowFriday Welcome to Ali Crichton who has recently joined the ICN committee as an Early Career Rep! Ali is a clinical neuropsychologist interested in single-case designs. Find out more about Ali: https://t.co/SsQjl6lkRn #nof1 #SCED @crichton_ali

In the most recent ICN selected paper, the authors reported on a study using a SCED to evaluate a mental health app. Read our summary: https://t.co/kf61yDTZOW #nof1 #SCED

The ICN has a LinkedIn page. Follow us: https://t.co/VmwSrlDejE #nof1 #SCED

Read about Professor Patrick Onghena's predictions for the field of single-case designs in our latest ICN interview: https://t.co/NZGk3NQHNz #nof1 #SCED @PatrickOnghena

Have you read a paper or book recently that you would like to see featured by the International Collaborative Network for N-of-1 Trials and Single-Case Designs? Contact us: https://t.co/TskbYN3qNB #nof1 #SCED

Check out the latest ICN blog! N-of-1 trials and single-case experimental designs in physiotherapy for musculoskeletal conditions: https://t.co/uKmX3bAOeR #nof1 #SCED @Kerrie__Evans @JaneNikles @MicheleSterlin7 @andrea_hams

Please RT ⬆️:@suzannem5 @JaneNikles @PatrickOnghena @wicksell_rikard @JohannesVlaeyen @SamuelDCalder @SRHarvey_ @crichton_ali @Nof1symposium

@JaneNikles @UQHealth @suzannem5 @RecoverResearch @petewnr @SKonigorski @ChronicPainAust @UQMedicine @Nic_Em_Andrews @rachelphinston

Learn more about N-of-1 trials and single-case experimental designs in physiotherapy for musculoskeletal conditions. New blog available! @JaneNikles @MicheleSterlin7